Estrace vs. Bijuva
See how Estrace and Bijuva compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Estrace is estrogen-only and usually requires a separate progestin for women with a uterus, while Bijuva combines bioidentical estradiol and progesterone in one capsule.
Both drugs carry boxed warnings for blood clots, stroke, heart attack, dementia, and breast cancer risk linked to hormone therapy.
Estrace covers a wider range of FDA-approved uses, while Bijuva is approved only for moderate to severe hot flashes in women who still have a uterus.
Estrace vs. Bijuva Drug Summary
Estrace
Estrace is an estrogen-only hormone therapy used for menopausal hot flashes, vaginal atrophy, and other estrogen-deficiency conditions. It comes as an oral tablet in several strengths, taken once daily or up to three times daily depending on the condition being treated. Women with a uterus typically need a separate progestin added to protect the uterine lining.
Bijuva
Bijuva is a combination hormone therapy that pairs bioidentical estradiol with bioidentical progesterone in a single oral capsule. It is FDA-approved specifically for moderate to severe hot flashes in menopausal women who still have a uterus. The built-in progesterone removes the need for a separate progestin prescription.
Estrace vs. Bijuva Side Effects
Estrace
Bijuva
Estrace vs. Bijuva Dosage
Estrace
Bijuva
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg three times daily | At the start |
| Maximum dose | 10 mg three times daily | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Estrace
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg three times daily | At the start |
| Maximum dose | 10 mg three times daily | Same as starting |
| Dose changes | None | Fixed dose |
Bijuva
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Estrace vs. Bijuva Indications
Estrace
Estrace is FDA-approved for a broad range of estrogen-deficiency conditions, including hot flashes, vaginal atrophy, and hypoestrogenism from ovarian failure or surgery. It is also used to help prevent bone loss after menopause and to palliate certain hormone-sensitive cancers. Dosing is adjusted depending on which condition is being treated.
Moderate to severe menopausal hot flashes
Vulvar and vaginal atrophy of menopause
Hypoestrogenism from ovarian failure or surgery
Bijuva
Bijuva is FDA-approved for one specific use: moderate to severe hot flashes caused by menopause in women who still have a uterus. It is not approved for vaginal atrophy, osteoporosis prevention, or use in women without a uterus. The estrogen and progesterone are combined to work together in a single daily capsule.
Moderate to severe menopausal hot flashes
Only for women with an intact uterus
Not approved for vaginal atrophy or osteoporosis
Estrace vs. Bijuva Pros and Cons
Estrace
Estrace has been prescribed since 1975 and offers multiple strengths and dosing schedules for different conditions. Because it contains estrogen alone, most women with a uterus need to add a separate progestin to reduce endometrial cancer risk. It is also available at a much lower list price than newer combination products.
Pros
Decades of clinical use with well-established safety data
Multiple strengths allow individualized dosing
Approved for a wider range of conditions, including vaginal atrophy and osteoporosis prevention
Cons
Estrogen-only formula usually requires a separate progestin for women with a uterus
Higher doses require dosing three times a day
2 mg tablet contains a dye (tartrazine) that can trigger allergic reactions in sensitive people
Bijuva
Bijuva combines bioidentical estradiol and progesterone in one capsule, so women with a uterus do not need a second prescription for endometrial protection. It is only approved for hot flashes, and no generic version exists yet, which keeps its cost well above older estrogen-only options. How the capsule is taken with food also affects progesterone absorption.
Pros
Single capsule combines estrogen and progestin, simplifying the regimen
Only FDA-approved bioidentical estradiol/progesterone combination
Once-daily dosing with just two strength options
Cons
Approved only for hot flashes, not vaginal atrophy or osteoporosis prevention
No generic version currently available
Must be taken with food, and a high-fat meal significantly changes absorption
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.